Yang Yu, Jing Wei, Chen Min, Yang Li, Li Xueya, Zhang Jing
Department of Cardiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, Anhui, China; The Fifth Clinical School of Medicine, Anhui Medical University, Hefei 230032, Anhui, China.
Department of Cardiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, Anhui, China.
Nutr Metab Cardiovasc Dis. 2025 Jun 26:104209. doi: 10.1016/j.numecd.2025.104209.
As a core risk factor for cardiovascular diseases, hypertension continues to be associated with a high global risk of major adverse cardiovascular events and mortality. Body roundness index (BRI), an emerging body morphology indicators reflecting central obesity and visceral fat accumulation through the ratio of waist circumference to height, is closely linked to cardiovascular risks such as hypertension. However, its value in assessing all-cause and cardiovascular mortality risks in hypertensive populations remains unclear. This study aimed to investigate the nonlinear association between BRI and all-cause mortality risk in hypertensive patients, evaluate its independent impact on cardiovascular mortality risk, and validate the robustness of results through subgroup analyses.
Using data from the National Health and Nutrition Examination Survey (NHANES), we included 8828 hypertensive patients with a median follow-up of 11.29 years, during which 2113 all-cause deaths (including 588 cardiovascular deaths) were recorded. By applying Cox proportional hazards models combined with restricted cubic splines (RCS), we found a nonlinear relationship between BRI and all-cause mortality risk in hypertensive patients, with a significant threshold effect. Competing risks model analysis showed that the impact of BRI on cardiovascular mortality risk was independent of other causes of death. Subgroup analyses further confirmed the robust association between BRI and mortality risk.
BRI may serve as an effective indicator for assessing all-cause and cardiovascular mortality risks in hypertensive patients. Its simplicity and cost-effectiveness suggest potential applications in clinical and public health practices.
作为心血管疾病的核心危险因素,高血压仍然与全球范围内主要不良心血管事件和死亡的高风险相关。身体圆润度指数(BRI)是一种新兴的身体形态指标,通过腰围与身高的比值反映中心性肥胖和内脏脂肪堆积,与高血压等心血管风险密切相关。然而,其在评估高血压人群全因和心血管死亡风险方面的价值仍不明确。本研究旨在探讨BRI与高血压患者全因死亡风险之间的非线性关联,评估其对心血管死亡风险的独立影响,并通过亚组分析验证结果的稳健性。
利用美国国家健康与营养检查调查(NHANES)的数据,我们纳入了8828例高血压患者,中位随访时间为11.29年,在此期间记录了2113例全因死亡(包括588例心血管死亡)。通过应用Cox比例风险模型结合限制性立方样条(RCS),我们发现高血压患者中BRI与全因死亡风险之间存在非线性关系,具有显著的阈值效应。竞争风险模型分析表明,BRI对心血管死亡风险的影响独立于其他死亡原因。亚组分析进一步证实了BRI与死亡风险之间的稳健关联。
BRI可能是评估高血压患者全因和心血管死亡风险的有效指标。其简单性和成本效益表明在临床和公共卫生实践中有潜在应用价值。